Tilray Brands Buys HelloMD to Build Vertically Integrated Cannabis Care
Tilray Brands is acquiring HelloMD to boost patient access and digital health tools within its Canadian medical cannabis operation.
Tilray Brands just made a move that signals it's serious about owning every piece of the medical cannabis puzzle in Canada. The company announced the acquisition of HelloMD, a digital healthcare platform, in a deal designed to pull patient access, clinical tools, and cannabis supply all under one roof.
If you're not familiar with HelloMD, think of it as the telehealth layer of the cannabis world — a platform that connects patients with healthcare practitioners who can authorize medical cannabis use. By bringing HelloMD into the fold, Tilray isn't just adding another company to its portfolio; it's plugging a critical gap between its existing cannabis products and the patients who need them.
Read more BC.GAME Brings Crypto-First iGaming Model to iGB L!VE 2026 →
For Tilray, this is about going fully vertically integrated on the medical side of the business. That's a fancy way of saying the company wants to control everything from growing the plant to getting it into a patient's hands — with the digital healthcare infrastructure in between. That kind of end-to-end control can mean tighter quality oversight, better data on patient outcomes, and potentially stronger margins over time.
The deal also strengthens Tilray's global medical cannabis ambitions. Canada has long served as a proving ground for regulated medical cannabis markets, and a more robust domestic platform could give Tilray a repeatable model it might eventually export to other markets where medical cannabis is gaining legal ground. Whether that plays out depends on execution, but the strategic logic is pretty straightforward: own the patient relationship, own the market.
Continue reading at GlobalNewswire.
